GET DAILY SIGNALSUnitedHealth Group (UNH) Delivers Strong Q3 Beat with Margin Gains and Raised Guidance
Key Takeaways
- UnitedHealth reported third quarter 2026 revenue of $112.7 billion and adjusted earnings per share (EPS) of $4.69, beating the analyst consensus of roughly $4.14.
- The medical care ratio (MCR), the share of premium revenue paid out for medical claims, improved to 88.4% from 89.9% a year earlier and came in below expectations.
- Management raised full-year 2026 adjusted EPS guidance to at least $20.50, up from a prior range of $19.50 to $20.00 — its third increase this year.
- The core insurance arm, UnitedHealthcare, lifted its operating margin to 3.3%, while the Optum Health unit swung to operating earnings of $735 million from $41 million a year ago.
- Despite the beat, shares closed down 0.20% at $377.76, suggesting much of the positive news was already priced in.
Earnings Context and Why It Matters
As the largest U.S. health insurer, UnitedHealth Group (UNH) acts as a bellwether for the managed care sector, so its results carry significant weight for investors following healthcare trends. The company has been executing a turnaround under CEO Stephen Hemsley, who returned to the role in 2025 after earlier challenges reduced substantial market value. Efforts have focused on exiting unprofitable areas, reducing exposure to low-margin value-based care, and tightening medical cost controls. This quarter provides insight into whether those steps are producing lasting margin improvement, with potential effects on peers such as Humana, CVS Health, and Centene.
Reported Results
In the third quarter of 2026, UnitedHealth recorded revenue of $112.7 billion, down slightly from $113.2 billion a year ago yet above the consensus estimate of about $111.3 billion. Adjusted EPS reached $4.69, well above the $4.14 expected by analysts and higher than $2.92 in the same period last year. On a GAAP basis, net income totaled $4.11 billion, or $4.56 per share, compared with $2.35 billion, or $2.59 per share, in the prior year.
The medical care ratio stood out, declining to 88.4% from 89.9% a year earlier and below the roughly 89.7% that analysts had modeled. The company credited better medical cost management, changes in benefit design, pricing discipline, and improvements in care delivery, along with $610 million in favorable prior-period reserve development related to 2026 service dates.
By segment, UnitedHealthcare produced $86.3 billion in revenue and $2.8 billion in operating earnings, raising its operating margin to 3.3% from 2.1%. Optum contributed $66.9 billion in revenue and $3.7 billion in operating earnings. Optum Health, previously a drag on results, reported operating earnings of $735 million versus $41 million a year ago, even with revenue down 10% after the company reduced activity in markets lacking sufficient scale.
Market Reaction and Investor Sentiment
Shares of UnitedHealth rose in premarket trading but finished the day down 0.20% at $377.76, close to the nearly flat performance of the S&P 500. Analysts observed that the beat and guidance increase had been largely anticipated after earlier outlook raises. Cantor Fitzgerald maintained an Overweight rating, noting the muted response reflected news that was already anticipated. The limited movement indicates investors are shifting focus to whether the improved medical cost trends can hold into 2027 and beyond.
Forward Outlook and Key Factors to Monitor
The updated full-year 2026 guidance of at least $20.50 in adjusted EPS reflects management’s view that the turnaround remains on track. Executives suggested on the call that the lower end of the long-term 13%–16% growth range represents a reasonable starting point for 2027 earnings, pointing to potential upside versus current consensus estimates.
Several elements will influence upcoming results. Medical cost trends continue to run above historical norms, with ongoing pressure from specialty pharmacy and acute care intensity in commercial lines. The Medicare Advantage enrollment period and 2027 Stars ratings, where at least 69% of members are in 4+ Star plans, will provide signals on membership trends and reimbursement quality.
Optum Health is expected to see a seasonally softer fourth quarter while investments continue in technology, AI, and workflow improvements. Medicaid margins are still negative, with 2026 viewed as a trough year before state funding aligns better with costs.
Capital returns remain active, with $5.0 billion in share repurchases and $6.2 billion in dividends paid year-to-date and a debt-to-capital ratio of 41.7% moving toward a 40% target. Investors will track whether cost discipline and business-mix shifts support ongoing margin expansion while maintaining the growth needed for longer-term objectives.
Using Tickeron’s AI Screener in My Research
When analyzing earnings movers like this one, I often turn to Tickeron’s AI Screener to quickly compare UnitedHealth with other healthcare names. The tool lets me apply filters for industry, performance metrics, and technical signals, helping surface ideas more efficiently than manual checks alone. It has become a regular part of how I build and refine watchlists across sectors.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
UNH sees its Stochastic Oscillator climbs out of oversold territory
On November 04, 2026, the Stochastic Oscillator for UNH moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 49 instances where the indicator left the oversold zone. In 34 of the 49 cases the stock moved higher in the following days. This puts the odds of a move higher at over 69%.
Technical Analysis (Indicators)
Bullish Trend Analysis
UNH moved above its 50-day moving average on October 14, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for UNH crossed bullishly above the 50-day moving average on October 19, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 44%.
Following a +2.23% 3-day Advance, the price is estimated to grow further. Considering data from situations where UNH advanced for three days, in 186 of 331 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.
The Aroon Indicator entered an Uptrend today. In 112 of 245 cases where UNH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 46%.
Bearish Trend Analysis
The 10-day RSI Indicator for UNH moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 35 similar instances where the indicator moved out of overbought territory. In 19 of the 35 cases, the stock moved lower in the following days. This puts the odds of a move lower at 54%.
The Momentum Indicator moved below the 0 level on November 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on UNH as a result. In 53 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 64%.
The Moving Average Convergence Divergence Histogram (MACD) for UNH turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 28 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 60%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UNH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 53%.
UNH broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating fairly steady price growth. UNH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 53 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.733) is normal, around the industry mean (3.512). P/E Ratio (26.242) is within average values for comparable stocks, (126.100). Projected Growth (PEG Ratio) (1.025) is also within normal values, averaging (0.786). UNH has a moderately high Dividend Yield (0.023) as compared to the industry average of (0.009). P/S Ratio (0.757) is also within normal values, averaging (0.569).
The Tickeron SMR rating for this company is 58 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 91 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UNH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of hospital and medical service plans
Industry ManagedHealthCare
Advertisement